YH-29407

N/A

Report date: 2025/06/11 14:30:59

NME

Base Information

Drug NameYH-29407

Drug Alias NameYH-29407

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitors

TargetsIndoleamine 2,3-dioxygenase

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesYuhan Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesYuhan Corp

Active IndicationsN/A

Inactive IndicationsSolid tumours

ATC CodeN/A